http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fc2440255b938245f97044f4be340e55
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Cox |
| name | David G Cox David G. Cox |
| given-name | David G. David G |
| organization-name | Hervé Ghesquieres, Universite Claude Bernard Lyon 1, Centre Leon Berard; Amelie S. Veron and David G. Cox, L'Institut National de la Santé et de la Recherche Médicale (INSERM) U1052, Cancer Research Center of Lyon, Centre Leon Berard, Lyon; Hervé Ghesquieres and Gilles A. Salles, Faculté de Médecine Lyon-Sud; Gilles A. Salles, Universite Claude Bernard Lyon 1, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Pierre-Bénite; Fabrice Jardin, Sylvain Mareschal, and Herve Tilly, INSERM U918, Centre Henri... 22Nurses' Health Study: Program in Molecular and Genetic Epidemiology, Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts (D.J.H., P.K., and D.G.C.) and Channing Laboratory, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts (D.J.H. and S.E.H.); 57Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom; Cancer Research Center of Lyon, INSERM UMR1052, Center Léon Bérard, Lyon, France. 2Department of Epidemiology and INSERM U1052, CNRS UMR5286, Université Lyon 1, Cancer Research Center of Lyon, Lyon, France,; Department of Epidemiology and Biostatistics, School of Public Health, Imperial College, London, UK, Department of Nuclear Medicine, Institut de Cancérologie Strasbourg Europe (ICANS), 17 Rue Albert Calmette, BP 23025, 67033 Strasbourg, France 66Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom.; 67Cancer Research Center of Lyon, INSERM UMR1052, Center Léon Bérard, Lyon, France. 5Program in Molecular and Genetic Epidemiology and 2Program in Molecular and Genetic Epidemiology,; 3Department of Epidemiology, Harvard School of Public Health, Boston Massachusettes; 3Program in Molecular and Genetic Epidemiology, Harvard School of Public Health; Divisions of 1Department of Epidemiology and; 2Program in Molecular and Genetic Epidemiology, Harvard School of Public Health; and 11Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts; Authors' Affiliations: 1Université de Lyon; 2Université Lyon 1, ISPB; 3Institut National de la Santé et de la Recherche Medicale (INSERM) U1052; 4Centre National de la Recherche Scientifique (CNRS) UMR5286, Centre de Recherche en Cancérologie de Lyon; 5Centre Léon Bérard, Pôle de Recherche Translationnelle; 6Department of Cancer, Environment, and Health Economics, Centre Léon Bérard, Lyon; 7Statlife, Cancer Campus, Bâtiment M. Tubiana; 8Breast Cancer Group and High-Risk Clinic; 9Institut Gustave Roussy, Villejuif; 10Ethics Research Department, University of Paris Sud, Le Kremlin Bicêtre; 11CNRS UMR 5824 GATE Lyon-St. Etienne, Ecully, France; and 12Department of Epidemiology and Biostatistics, School of Public Health, Imperial College, London, United Kingdom; Authors' Affiliations: 1Université de Lyon; 2Université Lyon 1, ISPB; 3Institut National de la Santé et de la Recherche Medicale (INSERM) U1052; 4Centre National de la Recherche Scientifique (CNRS) UMR5286, Centre de Recherche en Cancérologie de Lyon; 5Centre Léon Bérard, Pôle de Recherche Translationnelle; 6Department of Cancer, Environment, and Health Economics, Centre Léon Bérard, Lyon; 7Statlife, Cancer Campus, Bâtiment M. Tubiana; 8Breast Cancer Group and High-Risk Clinic; 9Institut Gustave Roussy, Villejuif; 10Ethics Research Department, University of Paris Sud, Le Kremlin Bicêtre; 11CNRS UMR 5824 GATE Lyon-St. Etienne, Ecully, France; and 12Department of Epidemiology and Biostatistics, School of Public Health, Imperial College, London, United Kingdom; Authors' Affiliations: 1Université de Lyon; 2Université Lyon 1, ISPB; 3Institut National de la Santé et de la Recherche Medicale (INSERM) U1052; 4Centre National de la Recherche Scientifique (CNRS) UMR5286, Centre de Recherche en Cancérologie de Lyon; 5Centre Léon Bérard, Pôle de Recherche Translationnelle; 6Department of Cancer, Environment, and Health Economics, Centre Léon Bérard, Lyon; 7Statlife, Cancer Campus, Bâtiment M. Tubiana; 8Breast Cancer Group and High-Risk Clinic; 9Institut Gustave Roussy, Villejuif; 10Ethics Research Department, University of Paris Sud, Le Kremlin Bicêtre; 11CNRS UMR 5824 GATE Lyon-St. Etienne, Ecully, France; and 12Department of Epidemiology and Biostatistics, School of Public Health, Imperial College, London, United Kingdom; Authors' Affiliations: 1Université de Lyon; 2Université Lyon 1, ISPB; 3Institut National de la Santé et de la Recherche Medicale (INSERM) U1052; 4Centre National de la Recherche Scientifique (CNRS) UMR5286, Centre de Recherche en Cancérologie de Lyon; 5Centre Léon Bérard, Pôle de Recherche Translationnelle; 6Department of Cancer, Environment, and Health Economics, Centre Léon Bérard, Lyon; 7Statlife, Cancer Campus, Bâtiment M. Tubiana; 8Breast Cancer Group and High-Risk Clinic; 9Institut Gustave Roussy, Villejuif; 10Ethics Research Department, University of Paris Sud, Le Kremlin Bicêtre; 11CNRS UMR 5824 GATE Lyon-St. Etienne, Ecully, France; and 12Department of Epidemiology and Biostatistics, School of Public Health, Imperial College, London, United Kingdom; Authors' Affiliations: 1Université de Lyon; 2Université Lyon 1, ISPB; 3Institut National de la Santé et de la Recherche Medicale (INSERM) U1052; 4Centre National de la Recherche Scientifique (CNRS) UMR5286, Centre de Recherche en Cancérologie de Lyon; 5Centre Léon Bérard, Pôle de Recherche Translationnelle; 6Department of Cancer, Environment, and Health Economics, Centre Léon Bérard, Lyon; 7Statlife, Cancer Campus, Bâtiment M. Tubiana; 8Breast Cancer Group and High-Risk Clinic; 9Institut Gustave Roussy, Villejuif; 10Ethics Research Department, University of Paris Sud, Le Kremlin Bicêtre; 11CNRS UMR 5824 GATE Lyon-St. Etienne, Ecully, France; and 12Department of Epidemiology and Biostatistics, School of Public Health, Imperial College, London, United Kingdom; Authors' Affiliations: 1Université de Lyon; 2Université Lyon 1, ISPB; 3Institut National de la Santé et de la Recherche Medicale (INSERM) U1052; 4Centre National de la Recherche Scientifique (CNRS) UMR5286, Centre de Recherche en Cancérologie de Lyon; 5Centre Léon Bérard, Pôle de Recherche Translationnelle; 6Department of Cancer, Environment, and Health Economics, Centre Léon Bérard, Lyon; 7Statlife, Cancer Campus, Bâtiment M. Tubiana; 8Breast Cancer Group and High-Risk Clinic; 9Institut Gustave Roussy, Villejuif; 10Ethics Research Department, University of Paris Sud, Le Kremlin Bicêtre; 11CNRS UMR 5824 GATE Lyon-St. Etienne, Ecully, France; and 12Department of Epidemiology and Biostatistics, School of Public Health, Imperial College, London, United Kingdom 1Program in Molecular and Genetic Epidemiology, Department of Epidemiology, and; 3Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School; 1Department of Epidemiology,; 2Program in Molecular and Genetic Epidemiology, Harvard School of Public Health; and 1Department of Epidemiology and; 2Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, and INSERM U1052 – Cancer Research Center of Lyon, Centre Léon Bérard, Lyon, France12Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, England Centre de Recherche en Cancerologie de Lyon Lyon France Cancer Research Center of Lyon, INSERM U1052, Lyon, France Institute of Cancer Strasbourg, Strasbourg, France Genome Analysis Group, International Agency for Research on Cancer, 69008 Lyon, France Centre de Recherche en Cancérologie de Lyon, INSERM U1052 - Centre Léon Bérard, 69373 Lyon, France Université de Lyon, F-69000 Lyon, France. School of Public Health, Imperial College; London United Kingdom |
Incoming Links
Total number of triples: 129.